 WATERTOWN, Mass., Jan. 17, 2023 GLOBE NEWSWIRE Lyra Therapeutics, Inc. Nasdaq: LYRA the Company or Lyra, a clinical-stage biotechnology company developing therapies for the localized treatment of patients with chronic rhinosinusitis CRS, today announced that it has issued an equity-based award pursuant to its 2022 Inducement Award Plan to its Senior Vice President of ... The post Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635c4 appeared first on ForexTV... 